ES422001A1 - Un procedimiento para la preparacion de nuevas imidazotria-zinas. - Google Patents

Un procedimiento para la preparacion de nuevas imidazotria-zinas.

Info

Publication number
ES422001A1
ES422001A1 ES422001A ES422001A ES422001A1 ES 422001 A1 ES422001 A1 ES 422001A1 ES 422001 A ES422001 A ES 422001A ES 422001 A ES422001 A ES 422001A ES 422001 A1 ES422001 A1 ES 422001A1
Authority
ES
Spain
Prior art keywords
triazines
imidazo
compounds
general formula
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES422001A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allen and Hanburys Ltd
Original Assignee
Allen and Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen and Hanburys Ltd filed Critical Allen and Hanburys Ltd
Publication of ES422001A1 publication Critical patent/ES422001A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
ES422001A 1973-01-04 1974-01-03 Un procedimiento para la preparacion de nuevas imidazotria-zinas. Expired ES422001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB55373*[A GB1457873A (en) 1973-01-04 1973-01-04 Imidazotriazines

Publications (1)

Publication Number Publication Date
ES422001A1 true ES422001A1 (es) 1976-08-01

Family

ID=9706420

Family Applications (1)

Application Number Title Priority Date Filing Date
ES422001A Expired ES422001A1 (es) 1973-01-04 1974-01-03 Un procedimiento para la preparacion de nuevas imidazotria-zinas.

Country Status (19)

Country Link
US (1) US3941785A (es)
JP (1) JPS4995994A (es)
AT (1) AT336029B (es)
AU (1) AU474078B2 (es)
BE (1) BE809369A (es)
CA (1) CA1005057A (es)
CH (1) CH618170A5 (es)
DE (1) DE2364076A1 (es)
ES (1) ES422001A1 (es)
FI (1) FI57260C (es)
FR (1) FR2213058B1 (es)
GB (1) GB1457873A (es)
IE (1) IE38681B1 (es)
IL (1) IL43872A (es)
LU (1) LU69099A1 (es)
NL (1) NL7400095A (es)
NO (1) NO140301C (es)
SE (1) SE408179B (es)
ZA (1) ZA739534B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
US4096257A (en) * 1977-05-23 1978-06-20 American Cyanamid Company Substituted imidazo [1,2-d]-as-triazines
US4107309A (en) * 1977-05-23 1978-08-15 American Cyanamid Company Substituted imidazo[1,2-d]-as-triazines
US4126444A (en) * 1977-11-22 1978-11-21 American Cynamid Company Substituted imidazo (1,5-D)-as-triazin-4-ols, and herbicidal use thereof
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
DD244681A3 (de) * 1985-12-02 1987-04-15 Zeiss Jena Veb Carl Vorrichtung zur positionierung von enden flexibler lichtleitelemente
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
SK287161B6 (sk) * 1997-11-12 2010-02-08 Bayer Healthcare Ag 2-Fenylsubstituované imidazotriazinóny, spôsob ich výroby, liečivá obsahujúce tieto látky a ich použitie
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
AU754379B2 (en) 1998-08-26 2002-11-14 Smithkline Beecham Corporation Therapies for treating pulmonary diseases
JP5038568B2 (ja) 1999-08-21 2012-10-03 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 協力剤の組合せ物
MXPA03010119A (es) * 2001-05-09 2005-03-07 Bayer Healthcare Ag Nuevo uso de imidazotriazinonas 2-fenilo sustituidas.
GB0113344D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
DE10130167A1 (de) * 2001-06-22 2003-01-02 Bayer Ag Imidazotriazine
DE10135815A1 (de) 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
DE10230605A1 (de) * 2002-07-08 2004-01-29 Bayer Ag Substituierte Imidazotriazine
DE10230604A1 (de) * 2002-07-08 2004-01-29 Bayer Ag Heterocyclisch substituierte Imidazotriazine
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
ATE432936T1 (de) * 2003-04-01 2009-06-15 Smithkline Beecham Corp Imidazotriazin verbindungen zur behandlung von krebserkrankungen
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
BRPI0616633A2 (pt) * 2005-09-29 2011-06-28 Bayer Healthcare Ag inibidores de pde e combinações dos mesmos para o tratamento de transtornos urológicos
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
AU2007223036A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2026813A2 (en) * 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7998971B2 (en) * 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
CN101711153A (zh) * 2007-06-13 2010-05-19 拜耳先灵制药股份公司 用于治疗听觉损伤的pde抑制剂
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) * 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques

Also Published As

Publication number Publication date
AT336029B (de) 1977-04-12
NO140301B (no) 1979-04-30
NO140301C (no) 1979-08-08
LU69099A1 (es) 1974-04-02
IL43872A0 (en) 1974-03-14
FI57260C (fi) 1980-07-10
IE38681B1 (en) 1978-05-10
FI57260B (fi) 1980-03-31
US3941785A (en) 1976-03-02
AU474078B2 (en) 1976-07-15
JPS4995994A (es) 1974-09-11
DE2364076A1 (de) 1974-07-18
ATA2374A (de) 1976-08-15
CA1005057A (en) 1977-02-08
ZA739534B (en) 1974-11-27
AU6377473A (en) 1975-06-19
FR2213058B1 (es) 1977-07-01
NL7400095A (es) 1974-07-08
BE809369A (fr) 1974-07-03
GB1457873A (en) 1976-12-08
IL43872A (en) 1979-01-31
SE408179B (sv) 1979-05-21
FR2213058A1 (es) 1974-08-02
IE38681L (en) 1974-07-04
CH618170A5 (es) 1980-07-15

Similar Documents

Publication Publication Date Title
ES422001A1 (es) Un procedimiento para la preparacion de nuevas imidazotria-zinas.
ES389371A1 (es) Procedimiento para la obtencion de derivados de 1-(1,3,4- tiadiazol-2-il)-imidazolidinona-(2).
ES389180A1 (es) Procedimiento para la preparacion de derivados de la dihi- dro-3,4 isoquinoleina.
ES409436A1 (es) Un procedimiento para la preparacion de nuevos derivados deisoindolina.
ES416495A1 (es) Un procedimiento para la preparacion de nuevos derivados deacido quinaldico.
FR2277589B1 (es)
ES418924A1 (es) Procedimiento para la obtencion de 13, 14-dihidroprosta- glandinas.
ES418114A1 (es) Un procedimiento para la preparacion de nuevas 5-metiltio pirimidinas.
ES428005A1 (es) Procedimiento para la preparacion de derivados de 3-4-dihi-dro-2h-naftalenom-(1)-5-oxi-propil-piperazina.
ES427291A1 (es) Un procedimiento para preparar nuevos compuestos esteroi- des.
SE7409707L (es)
ES437869A1 (es) Un procedimiento para preparar nuevos 5,6 dimetoxiindazoles sustituidos en 2.
ES412372A1 (es) Un procedimiento para la preparacion de compuestos biologi-camente activos.
ES368721A1 (es) Procedimiento para la obtencion de derivados de ergopeptina.
ES425809A1 (es) Procedimiento para la preparacion de compuestos tetracicli-cos sustituidos por amino.
ES429871A1 (es) Procedimiento de preparacion de derivados 1, 3-benzodioxol.
ES376149A1 (es) Procedimiento para la preparacion de derivados del boro.
IE38221L (en) Pyrimidinoheterocyclic compounds
ES432939A1 (es) Procedimiento de preparacion de nuevos azabicicloalcanos disustituidos.
ES421281A1 (es) Procedimiento para la produccion de penicilinas.
ES425628A1 (es) Procedimiento de preparacion de derivados de piperidina sustituidos con amino.
ES417971A1 (es) Procedimiento para la obtencion de diabenzazecinas.
ES423950A1 (es) Procedimiento para la preparacion de 3 - carbetoxihidrazino- piridazinas - 6 - sustituidas.
ES404463A1 (es) Procedimiento para la produccion de 6-hidroxi-dihidro-ura- cilos.
ES421130A1 (es) Procedimiento para preparar derivados de ditiino (1,4) (2, 3-c) pirrol.